What is the recommended dosing of Metronidazole (Flagyl) for bacterial vaginosis (BV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended dosing of Metronidazole for bacterial vaginosis (BV) is 500 mg orally twice a day for 7 days, as this regimen has been shown to be effective in treating BV and preventing complications such as pelvic inflammatory disease and pregnancy complications 1.

Key Considerations

  • Metronidazole works by disrupting DNA synthesis in anaerobic bacteria that cause BV, particularly Gardnerella vaginalis and other anaerobes that replace normal vaginal lactobacilli.
  • Patients should avoid alcohol during treatment and for 24-48 hours afterward to prevent disulfiram-like reactions.
  • Alternative regimens include metronidazole gel 0.75%, one full applicator (5 g) intravaginally, once a day for 5 days, or clindamycin cream 2%, one full applicator (5 g) intravaginally at bedtime for 7 days 1.
  • A single 2-gram oral dose of metronidazole can also be used, but may have lower cure rates 1.

Important Notes

  • Treatment is important even for asymptomatic women as BV can increase risk of complications.
  • Sexual partners typically don't require treatment, but recurrence is common (30-50% within 3 months), and longer suppressive therapy may be needed for frequent recurrences.
  • The choice of treatment regimen should be based on patient preference, side effect profile, and cost considerations.

From the Research

Metronidazole Dosing for Bacterial Vaginosis (BV)

  • The recommended dosing of Metronidazole for BV varies depending on the patient's pregnancy status and the severity of the infection.
  • For nonpregnant women, the recommended treatment is metronidazole (500 mg orally twice daily for 7 days) 2.
  • For pregnant women, the recommended treatment is metronidazole (250 mg orally three times a day for 7 days), regardless of their risk status 2.
  • For recurrent BV, an extended course of metronidazole treatment (500 mg twice daily for 10-14 days) is recommended 3.
  • If the extended course is ineffective, metronidazole vaginal gel 0.75% for 10 days, followed by two times per week for 3-6 months, is an alternate treatment regimen 3.

Alternative Treatment Options

  • Clindamycin vaginal cream (2%, once daily for 7 days) is also an effective treatment option for BV 2, 4.
  • Metronidazole vaginal gel (0.75%, twice daily for 5 days) is another alternative treatment option 2, 5.
  • Oral clindamycin (300 mg twice daily) may also be effective in treating BV 6.

Treatment Efficacy

  • The cure rates for oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream are similar, ranging from 72% to 87% 4, 5.
  • The choice of treatment may depend on patient preference, side effects, and the presence of other infections, such as vulvovaginal candidiasis 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999

Research

Characterization and Treatment of Recurrent Bacterial Vaginosis.

Journal of women's health (2002), 2019

Research

Treatment of sexually transmitted vaginosis/vaginitis.

Reviews of infectious diseases, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.